Or Refractory Diffuse Large B-cell Lymphoma
📧 Sign up to get email alerts when something new happens for Or Refractory Diffuse Large B-cell Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2025-10-03Clinical Trial Update: Study of Selinexor in Combination With Backbone Treatments or Novel Therapies In Participants With Relapsed or Refractory (RR) Diffuse Large B-Cell Lymphoma (DLBCL) [Phase 1, Phase 2]
Withdrawal of a Phase 1/2 clinical trial evaluating selinexor in combination regimens for relapsed or refractory diffuse large B-cell lympho…